[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-247123-105":3,"detail-sidebar-cat-1-en-105":81,"doc-detail-247123-en":127},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ilpqc-covid-19-webinar-ob-questionsanswers-41720","ILPQC COVID-19 Webinar - OB Questions/Answers - 4/17/20","","A question-and-answer transcript from the ILPQC COVID-19 webinar dated 4/17/20, collecting experience-based approaches from individual providers and institutions. Topics include limiting fetal monitoring and entry into COVID PUI/+ rooms in antepartum care, using telemetry and relocating monitors to reduce exposure during ICU admissions, and PPE guidance for second-stage labor and cesarean delivery. It also covers visitor/support-person rules using screening or POC testing, oxygen use in intrauterine fetal resuscitation versus treating maternal or neonatal respiratory symptoms, and resident participation in Stage II deliveries and neonatal resuscitation workflows.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/template/","Template",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/template/presentations/","Presentations",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/template/ilpqc-covid-19-webinar-ob-questionsanswers-41720/247123/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ilpqc-covid-19-webinar-ob-questionsanswers-41720/247123.png","ImageObject",442,249,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-19","2026-09-12",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How should fetal monitoring be handled for COVID PUI/+ patients near viability in the antepartum setting?","Question",{"text":63,"@type":64},"Approaches focus on limiting the frequency of fetal monitoring and heart-tone assessment to medically necessary times to reduce PPE use and staff exposure. When monitoring is needed around periviability or critically ill patients, risk-benefit discussions for interventions such as cesarean delivery should be individualized.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What monitoring options can reduce staff exposure when a COVID+ mother requires ICU admission for unstable oxygen saturation?",{"text":68,"@type":64},"Telemetry is recommended to avoid prolonged exposure, including moving the monitor toward a window when feasible. Adoption can be limited by availability of long cables and wireless technology, but some institutions report implementing this for ICU cases.",{"name":70,"@type":61,"acceptedAnswer":71},"Should oxygen be continued as part of intrapartum fetal resuscitation during the pandemic?",{"text":72,"@type":64},"Some institutions eliminated oxygen from their intrauterine fetal resuscitation protocols, relying instead on other measures for fetal heart rate decelerations. Oxygen may still be used when treating maternal or neonatal respiratory symptoms or when maternal oxygen needs are driven by conditions like COPD or asthma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},247123,1791734543,{"code":4,"msg":82,"data":83},"success",[84,88,93,98,103,108,113,118,123],{"id":85,"doc_module":22,"doc_module_name":25,"category_name":29,"show_sort_weight":86,"slug":87},11,90,"presentations",{"id":89,"doc_module":22,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},12,"Resumes",80,"resumes",{"id":94,"doc_module":22,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},14,"Invoices",70,"invoices",{"id":99,"doc_module":22,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},15,"Posters",60,"posters",{"id":104,"doc_module":22,"doc_module_name":25,"category_name":105,"show_sort_weight":106,"slug":107},16,"Social Media",50,"social-media",{"id":109,"doc_module":22,"doc_module_name":25,"category_name":110,"show_sort_weight":111,"slug":112},17,"Forms",40,"forms",{"id":114,"doc_module":22,"doc_module_name":25,"category_name":115,"show_sort_weight":116,"slug":117},18,"Letters",30,"letters",{"id":119,"doc_module":22,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},21,"Paper Templates",5,"papers-templates",{"id":124,"doc_module":22,"doc_module_name":25,"category_name":125,"show_sort_weight":4,"slug":126},158,"General","general-158",{"code":4,"msg":82,"data":128},{"doc_id":79,"user_id":129,"nickname":42,"user_avatar":130,"doc_module":22,"category_id":85,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":136,"language":137,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":138,"faqs":139,"seo_title":140,"seo_description":12,"update_tm":141,"read_time":142},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","ILPQC COVID 19 Webinar 4/17/20: OB Questions/Answers  \nAnswers represent experiences and strategies related to caring for patients during the COVID-19 pandemic from individual providers and institutions,  \nthese example strategies are not meant to be recommendations unless national or state guidelines are referenced.  \nQuestions from the 4/17 webinar chatbox, the Info Account, and Registration  \nAntepartum  \n• In the presence of COVID PUI/+ patients in the antepartum setting, have there been any discussions around limiting or reducing the fetal monitoring for these patients when they’re on the cusp of viability or when their issues aren’t necessarily related to the  \nmortality/morbidity of the baby? The first instinct seems to frequently be to place moms on continuous monitoring. However, in the suspicion/presence of COVID we should be limiting the amount that we are in and out of these rooms; not only to conserve PPE but also to protect staff. Particularly in cases where gestational age is low and/or mom’s body habitus makes monitoring challenging. Of course, I’m not speaking of times when it’s unavoidable or medically necessary. Just wondering if there has been any dialogue in regards to this.  \no At NorthShore, we have been trying to limit the frequency of fetal monitoring/heart tone assessment to those times that are medically necessary. An OB provider when rounding on the patient may obtain heart tones to avoid asking another individual to come to the room to do it. Monitoring around the time of periviability with a critically ill patient warrants an in-depth discussion of maternal/fetal risk and benefit of cesarean delivery for non-reassuring fetal status. Monitoring should be individualized accordingly.  \no Fetal monitoring procedures should be considered based on clinical circumstances. Very few clinical antepartum conditions (eg variable decelerations early preterm – velamentous insertion of the cord) requires continuous FHR monitoring. We agree to limiting the number of health care providers entering the COVID + patient’s room.  \n• For a COVID + mom requiring an ICU admission and count EFM due to unstable O2 sats, any recommendations for monitoring that would avoid an LD nurse having prolonged exposure. We are considering using telemetry and moving the monitor to the glass window.  \no Telemetry is an excellent option to avoid prolonged exposure.  \no Similar procedures are implemented across the nation. Major obstacles have been absence of long cables and wireless technology availability.  \no At Loyola we have done exactly that for our ICU cases, moving the monitor to the window so that our nurse may remain outside the patient’s room as feasible.  \nL&D  \n• second stage risk?  \no I think the question is asking about the recommendation for PPE / n95 and face shield in the 2nd stage. Given the 2nd stage and a cesarean delivery is potentially aerosolizing and the risk of asymptomatic patients. Hospitals have been moving to have all providers and staff in n95 masks and face shields for all 2nd stage, delivery and cesarean delivery.  \no At Rush, with Universal Screening for Covid we are only doing this for COIVD+ patients or those who refuse testing on admission. If a woman has no history of COVID, no symptoms and has a negative point of care test on admission, we are not using N95 at delivery.  \no The risk of not using n95 when have a negative rapid point of care test, is the risk of false negative cases, benefit is conserving PPE. The sensitivity of the rapid test and prevalence in the community is important to consider.  \n• What are other facilities doing about the significant other that is allowed in the room for delivery?  \no For known Covid patients, NorthShore does not allow a significant other as a visitor or in the delivery. For a person who becomes a PUI while in patient, the support person is treated like a PUI, is given a mask and is asked not to leave the room. If the support person leaves, he/she is not allowe","cbCaipk15dK70XJe","https://ap.wps.com/l/cbCaipk15dK70XJe","pdf",307272,20,"English","# Antepartum\n## Fetal monitoring frequency and room-entry limitation\n## ICU monitoring and exposure reduction\n# L&D\n## PPE/N95 and face shield in second stage\n## Visitor/support-person policy during delivery\n## Oxygen use for mother and baby; NeoPuff vs Ambu bag\n## Intrapartum fetal resuscitation oxygen guidance\n## Resident physician involvement in Stage II and Neo resuscitations","[{\"question\":\"How should fetal monitoring be handled for COVID PUI/+ patients near viability in the antepartum setting?\",\"answer\":\"Approaches focus on limiting the frequency of fetal monitoring and heart-tone assessment to medically necessary times to reduce PPE use and staff exposure. When monitoring is needed around periviability or critically ill patients, risk-benefit discussions for interventions such as cesarean delivery should be individualized.\"},{\"question\":\"What monitoring options can reduce staff exposure when a COVID+ mother requires ICU admission for unstable oxygen saturation?\",\"answer\":\"Telemetry is recommended to avoid prolonged exposure, including moving the monitor toward a window when feasible. Adoption can be limited by availability of long cables and wireless technology, but some institutions report implementing this for ICU cases.\"},{\"question\":\"Should oxygen be continued as part of intrapartum fetal resuscitation during the pandemic?\",\"answer\":\"Some institutions eliminated oxygen from their intrauterine fetal resuscitation protocols, relying instead on other measures for fetal heart rate decelerations. Oxygen may still be used when treating maternal or neonatal respiratory symptoms or when maternal oxygen needs are driven by conditions like COPD or asthma.\"}]","ILPQC COVID-19 Webinar - OB Questions/Answers - 4/17/20 | PDF",1789240088,7]